Inventor · disambiguated record
Steven P. Treon
Also filed as: TREON STEVEN P
14 granted patents·5 pending applications·59 citations·filing 1992–2021
90Inventor score
Top patents by PatentIndex Score
19 records- 0189US9856223B2Methods to treat lymphoplasmacytic lymphomaDANA FARBER CANCER INST INC·Filed 2014·Granted Jan 2, 2018·6 cites·23 claims
- 0285US10112957B2Thiazolyl-containing compounds for treating proliferative diseasesDANA FARBER CANCER INST INC·Filed 2015·Granted Oct 30, 2018·5 cites·35 claims
- 0384US10525060B2HCK as a therapeutic target in MYD88 mutated diseasesDANA FARBER CANCER INST INC·Filed 2017·Granted Jan 7, 2020·5 cites·15 claims
- 0483US9908872B2Methods to treat lymphoplasmacytic lymphomaDANA FARBER CANCER INST INC·Filed 2014·Granted Mar 6, 2018·6 cites·26 claims
- 0582US11739385B2Discovery of a somatic mutation in MYD88 gene in lymphoplasmacytic lymphomaDANA FARBER CANCER INST INC·Filed 2019·Granted Aug 29, 2023·1 cites·15 claims
- 0681US10633348B2Methods to treat lymphoplasmacytic lymphomaDANA FARBER CANCER INST INC·Filed 2017·Granted Apr 28, 2020·1 cites·29 claims
- 0780US10464949B2Thiazolyl-containing compounds for treating proliferative diseasesDANA FARBER CANCER INST INC·Filed 2018·Granted Nov 5, 2019·2 cites·32 claims
- 0879US10526660B2Methods for evaluating and treating Waldenstrom's macroglobulinemiaDANA FARBER CANCER INST INC·Filed 2014·Granted Jan 7, 2020·2 cites·22 claims
- 0976US10465247B2Discovery of a somatic mutation in MYD88 gene in lymphoplasmacytic lymphomaTREON STEVEN P·Filed 2012·Granted Nov 5, 2019·2 cites·20 claims
- 1075US10612095B2Methods to distinguish Waldenström's Macroglobulinemia from IgM monoclonal gammopathy of undetermined significanceDANA FARBER CANCER INST INC·Filed 2014·Granted Apr 7, 2020·1 cites·15 claims
- 1173US10597387B2Methods to treat lymphoplasmacytic lymphomaDANA FARBER CANCER INST INC·Filed 2018·Granted Mar 24, 2020·1 cites·30 claims
- 1265USRE50030EMethods to treat lymphoplasmacytic lymphomaDANA FARBER CANCER INST INC·Filed 2014·Granted Jul 2, 2024·0 cites·33 claims
- 1360US2020199683A1Methods for evaluating and treating waldenstrom's macroglobulinemiaDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
- 1459US10844077B2Thiazolyl-containing compounds for treating proliferative diseasesDANA FARBER CANCER INST INC·Filed 2019·Granted Nov 24, 2020·0 cites·27 claims
- 1557US5230886ATumor cell suppressionUNIV BOSTON·Filed 1992·Granted Jul 27, 1993·27 cites·14 claims
- 1653US2024034726A9Map kinase kinase (mkk7) inhibitors and uses thereofDANA FARBER CANCER INST INC·Filed 2021·Application pending·0 cites
- 1753US2023339865A1Quinazoline-derived hck inhibitors for use in the treatment of myd88 mutated diseasesDANA FARBER CANCER INST INC·Filed 2021·Application pending·0 cites
- 1851US2023058545A1Hck as a therapeutic target in myd88 mutated diseasesDANA FARBER CANCER INST INC·Filed 2020·Application pending·0 cites
- 1951US2022372017A1Hck degraders and uses thereofDANA FARBER CANCER INST INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Steven P. Treon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →